Literature DB >> 11032381

Anxiety in healthy humans is associated with orbital frontal chemistry.

I D Grachev1, A V Apkarian.   

Abstract

The present study examines relationships between regional brain chemistry (as identified by localized in vivo three-dimensional single-voxel proton magnetic resonance spectroscopy (1H-MRS) and anxiety (as measured by the State-Trait Anxiety Inventory) in 16 healthy subjects. The relative concentrations of N-Acetyl aspartate, choline, glutamate, glutamine, gamma-aminobutyric acid, inositol, glucose and lactate were measured relative to creatine within six 8-cm3 brain voxels localized to: thalamus, cingulate, insula, sensorimotor, dorsolateral prefrontal, and orbital frontal cortices (OFC) in the left hemisphere. Analysis of variance, across brain regions, chemicals, and high and low anxiety groups, showed a relationship between anxiety and chemical composition of OFC, with high anxiety subjects demonstrating 32% increase in overall chemical concentrations within OFC, as compared to the lower anxiety group (F= 60.8, P < 10(-7)). Other brain regions, including cingulate, showed no detectable anxiety dependence. The combination of the state and trait anxiety was highly correlated with the concentration of OFC chemicals (r2 = 0.98), and N-Acetyl aspartate in OFC was identified as the strongest chemical marker for anxiety (changed by 43.2% between the two anxiety groups, F = 21.5, P = 0.000005). The results provide direct evidence that the OFC chemistry is associated with anxiety in healthy humans. The method can be used as a neuroimaging/behavioral tool for documentation of OFC chemistry changes in relation to anxiety per se and anxiety disorders. The presented relationship between regional brain chemistry and anxiety reflects the functional/behavioral state of the brain, pointing to possible mechanisms of the neurobiology of anxiety.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032381     DOI: 10.1038/sj.mp.4000778

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  19 in total

1.  On the importance of inhibition: central and peripheral manifestations of nonlinear inhibitory processes in neural systems.

Authors:  Julian F Thayer
Journal:  Dose Response       Date:  2006-06-20       Impact factor: 2.658

2.  Relevance of orbitofrontal neurochemistry for the outcome of cognitive-behavioural therapy in patients with obsessive-compulsive disorder.

Authors:  Bartosz Zurowski; Andreas Kordon; Wolfgang Weber-Fahr; Ulrich Voderholzer; Anne Katrin Kuelz; Tobias Freyer; Karina Wahl; Christian Büchel; Fritz Hohagen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-17       Impact factor: 5.270

3.  Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.

Authors:  Iris Crespo; Alicia Santos; Beatriz Gómez-Ansón; Olga López-Mourelo; Patricia Pires; Yolanda Vives-Gilabert; Susan M Webb; Eugenia Resmini
Journal:  Endocrine       Date:  2016-04-21       Impact factor: 3.633

4.  Structural evidence for involvement of a left amygdala-orbitofrontal network in subclinical anxiety.

Authors:  Karen Blackmon; William B Barr; Chad Carlson; Orrin Devinsky; Jonathan DuBois; Daniel Pogash; Brian T Quinn; Ruben Kuzniecky; Eric Halgren; Thomas Thesen
Journal:  Psychiatry Res       Date:  2011-07-30       Impact factor: 3.222

5.  Chemical mapping of anxiety in the brain of healthy humans: an in vivo 1H-MRS study on the effects of sex, age, and brain region.

Authors:  I D Grachev; A V Apkarian
Journal:  Hum Brain Mapp       Date:  2000-12       Impact factor: 5.038

6.  Spontaneous activity in medial orbitofrontal cortex correlates with trait anxiety in healthy male adults.

Authors:  Shao-Wei Xue; Tien-Wen Lee; Yong-Hu Guo
Journal:  J Zhejiang Univ Sci B       Date:  2018 Aug.       Impact factor: 3.066

Review 7.  Interactions between age, sex, and hormones in experimental ischemic stroke.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Neurochem Int       Date:  2012-10-13       Impact factor: 3.921

8.  Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.

Authors:  Sanjay J Mathew; Rebecca B Price; Xiangling Mao; Eric L P Smith; Jeremy D Coplan; Dennis S Charney; Dikoma C Shungu
Journal:  Biol Psychiatry       Date:  2007-10-29       Impact factor: 13.382

9.  Distinguishing expected negative outcomes from preparatory control in the human orbitofrontal cortex.

Authors:  Stefan Ursu; Kristi A Clark; V Andrew Stenger; Cameron S Carter
Journal:  Brain Res       Date:  2008-06-19       Impact factor: 3.252

10.  Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.

Authors:  Peter Zwanzger; Maxim Zavorotnyy; Elena Gencheva; Julia Diemer; Harald Kugel; Walter Heindel; Tillmann Ruland; Patricia Ohrmann; Volker Arolt; Katharina Domschke; Bettina Pfleiderer
Journal:  Neuropsychopharmacology       Date:  2013-03-05       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.